No Data
Top 3 Health Care Stocks That May Rocket Higher In April
Goldman Sachs: The Q1 performance of U.S. pharmaceutical stocks is reassuring, and the Industry sentiment is slightly becoming more positive.
Goldman Sachs stated that amid cautious sentiment from investors towards the USA pharmaceutical sector before the Earnings Reports season, the performance of USA pharmaceutical companies that have reported results so far for the first quarter has not been worse than expected, and in some cases, it has even exceeded expectations.
Express News | Bristol-Myers Squibb : HSBC Cuts Target Price to $47 From $56
Notable Healthcare Headlines for the Week: Merck, Roche and Bausch Health in Focus
No Misses Here: Healthcare Earnings Sweep Past Wall Street Estimates
Is Bristol-Myers Squibb Company (NYSE:BMY) A High Quality Stock To Own?
